A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)

OBJECTIVE: To examine the effects of naltrexone/bupropion (NB) combination therapy on weight and weight-related risk factors in overweight and obese participants. DESIGN AND METHODS: CONTRAVE Obesity Research-II (COR-II) was a double-blind, placebo-controlled study of 1,496 obese (BMI 30-45 kg/m(2))...

Descripción completa

Detalles Bibliográficos
Autores principales: Apovian, Caroline M, Aronne, Louis, Rubino, Domenica, Still, Christopher, Wyatt, Holly, Burns, Colleen, Kim, Dennis, Dunayevich, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2013
Materias:
Clinical Trials: Behavior, Pharmacotherapy, Devices, Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739931/
https://www.ncbi.nlm.nih.gov/pubmed/23408728
http://dx.doi.org/10.1002/oby.20309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739931/
https://www.ncbi.nlm.nih.gov/pubmed/23408728
http://dx.doi.org/10.1002/oby.20309

Ejemplares similares